Characterizing the HER2/neu Status and Metastatic Potential of Breast Cancer Stem/Progenitor Cells

被引：0
|
作者：
SuEllen J. Pommier
Glenda G. Quan
Dara Christante
Patrick Muller
Amy E. H. Newell
Susan B. Olson
Brian Diggs
Leslie Muldoon
Edward Neuwelt
Rodney F. Pommier
机构：
[1] Oregon Health & Science University,Division of Surgical Oncology, Department of General Surgery
[2] Oregon Health & Science University,Cytogenetics Research Laboratory
[3] Oregon Health & Science University,Department of Neurology, Blood Brain Barrier Institute
来源：
Annals of Surgical Oncology | 2010年 / 17卷
关键词：
Breast Cancer; Cancer Stem Cell; HCC1954 Cell; Cell Surface Marker; Normal Breast Tissue;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：613 / 623
页数：10
相关论文
共 50 条
  • [1] Characterizing the HER2/neu Status and Metastatic Potential of Breast Cancer Stem/Progenitor Cells
    Pommier, SuEllen J.
    Quan, Glenda G.
    Christante, Dara
    Muller, Patrick
    Newell, Amy E. H.
    Olson, Susan B.
    Diggs, Brian
    Muldoon, Leslie
    Neuwelt, Edward
    Pommier, Rodney F.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (02) : 613 - 623
  • [2] Characterizing The HER2/neu Status And Metastatic Potential Of Breast Cancer Stem/progenitor Cells
    Pommier, S.
    Quan, G.
    Christante, D.
    Muller, P.
    Neuwelt, E.
    Hanlon-Newell, A.
    Olson, S. B.
    Pommier, R.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 51 - 51
  • [3] HER2/neu status in primary breast cancer and in metastatic site as detected using FNA
    Giotta, Francesco
    Asselti, Maria Consilia
    Petroni, Stella
    Popescu, Onsina
    Rubini, Vincenza
    Latorre, Agnese
    Lorusso, Vito
    Gadaleta, Cosimo
    Simone, Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Behaviour and metastatic potential of her2/neu positive and her2/neu negative circulating epithelial tumor cells (CETC) during adjuvant systemic therapy in breast cancer
    Camara, O.
    Hammer, U.
    Gajda, M.
    Kroll, T.
    Krauspe, S.
    Gellner, A-K
    Joerke, C.
    Runnebaum, I. B.
    Hoeffken, K.
    Pachmann, K.
    CANCER RESEARCH, 2009, 69 (02) : 310S - 310S
  • [5] Targeted Therapy in Metastatic Breast Cancer: The HER2/neu Oncogene
    Harbeck, Nadia
    Pegram, Mark D.
    Rueschoff, Josef
    Moebus, Volker
    BREAST CARE, 2010, 5 : 3 - 7
  • [6] Ets expression in breast cancer with known HER2/neu status - potential therapeutic targets
    Myers, E
    Hill, ADK
    McDermott, EW
    O'Higgins, NJ
    Young, LS
    BRITISH JOURNAL OF SURGERY, 2003, 90 : 101 - 102
  • [7] Her2/neu status in locally advanced breast cancer.
    Doran, CM
    Cameron, DA
    Watters, AD
    Leonard, RCF
    Bartlett, JMS
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 278 - 278
  • [8] Reassessment of HER2 status in breast cancer patients at the time of metastatic disease by serum HER2 and HER2 status of circulating tumor cells
    Fehm, Tania
    TUMOR BIOLOGY, 2007, 28 : 22 - 22
  • [9] HER2/neu vaccines in breast cancer
    Khoo, Steven
    Ponniah, Sathibalan
    Peoples, George E.
    WOMENS HEALTH, 2006, 2 (02) : 217 - 223
  • [10] Efficacy of HER2 inhibitors in metastatic breast cancer by discordance in HER2 amplification status between primary and metastatic breast cancer
    Van Raemdonck, E.
    Berteloot, P.
    Laenen, A.
    Han, S.
    Van Nieuwenhuysen, E.
    Salihi, R.
    Concin, N.
    Vergote, I.
    Floris, G.
    Wildiers, H.
    Punie, K.
    Neven, P.
    CANCER RESEARCH, 2019, 79 (04)
12345